60-80% of patients avoided surgery for a year or longer in trial

An international trial led by UK universities reveals chemotherapy and radiotherapy combinations may eliminate the need for surgery in early-stage rectal cancer patients.

Around 80 per cent of patients were spared radical surgery following the trial treatment